Výroční konference EAFP 2023
For more than 20 years, Peter Kollár has been committed to experimental pharmacology and the mechanisms of action of the substances studied. Together with his team, he is currently looking for ways to enhance the effects of anti-tumour immunotherapy in combination with other substances.